As leaders in the field of spine surgery, The Spine Institute is often in the news for pioneering revolutionary surgical and minimally invasive spinal procedures.
March 15, 2017
Mesoblast Limited (MESO), Reports Positive Phase 2 Results of Mesenchymal Precursor Cells in Patients with CLBP-Related Intervertebral Disc Degeneration.
July 1, 2015
Spinal News, the international news outlet for spine physicians, recently caught up with Dr. Bae to discuss the high points of his career and find out what he thinks the future holds for spinal medicine.
May 1, 2015
A specialized news source in the spinal arena, Spinal News International is a trusted provider of latest news, review of cutting-edge research, congress coverage and opinion from thought leaders.
February 4, 2015
Dr. Bae is director of spine education at Cedars-Sinai Medical Center. In addition to his clinical work, Dr. Bae has spent a great deal of time researching stem cell repair for degenerative disc disease and the use of growth factors to treat spinal cord injuries.
January 27, 2015
The spine industry has experienced a Renaissance period for the past few decades where innovation truly disrupted the old open spine surgeries of the past, making procedures less risky and painful.
November 12, 2014
Stryker Corporation’s Spine Division will be launching its innovative Anchor-based ALIF technology, Aero™-AL, at booth #1405 during the North American Spine Society’s Annual Meeting in San Francisco, CA from November 12 – 14.
November 13, 2014
Mesoblast’s Phase 2 trial results in degenerative disc disease were presented today at the North American Spine Society (NASS) Annual Meeting. The key outcome of the trial was that a single injection of Mesoblast’s proprietary allogeneic Mesenchymal Precursor Cell (MPC) product resulted in sustained improvements in pain and function at 12 months.
September 23, 2014
Beckers Orthopedic & Spine Review, a leading resource offering news and analysis on business and legal issues relating to orthopedic and spine practices, has just released their list of the top spine surgeons to know for 2014.
September 14, 2014
An interdisciplinary research team in the Cedars-Sinai Biomedical Imaging Research Institute, Department of Biomedical Sciences, Regenerative Medicine Institute and Department of Surgery received a grant from the National Institutes of Health (NIH) to develop the first imaging technique used to identify biomarkers that could indicate patients have a painful, degenerative back condition.
September 10, 2014
The Cedars-Sinai Regenerative Medicine Institute, Biomedical Imaging Research Institute and the Department of Surgery received a $2.8 million grant from the National Institutes of Health (NIH) to aid in the development of the first-ever imaging technique used to diagnose patients suffering from a painful degenerative back condition. By actively identifying the location of pain, researchers hope to alleviate the need for painful diagnostic procedures and in the future, provide targeted, stem-cell based therapeutics to affected individuals.
July 6, 2014
If all goes according to plan, an experimental therapy now being tested at Cedars-Sinai Medical Center could soon provide relief to those who suffer severe back pain. Dr. Hyun Bae, director of spine education at the sprawling West Hollywood hospital’s Spine Center, is the first doctor in Los Angeles to use an experimental treatment on his patients. He injects adult stem cells into the discs that act as a cushion between vertebrae.
October 25, 2013
LDR Holding Corporation, a global medical device company, announced that Dr. Hyun Bae, Medical Director and Director of Spine Education at Cedars-Sinai in Los Angeles, CA presented 48-month safety and efficacy data of both one-level and two-level cervical disc replacement with Mobi-C® compared to traditional anterior cervical discectomy and fusion (ACDF).
January 18, 2013
Hyun Bae, MD, has researched stem cell repair for degenerative disc disease and the use of growth factors to treat spinal cord injuries. He was among the first to use growth factor tissue engineering for intervertebral discs and chaired the “Spine Across the Sea” meeting in 2012 for the North American Spine Society.
February 29, 2012
Dr. Bae is the co-director of the spine fellowship program at Cedars-Sinai Medical Center. He has a special interest in minimally invasive spine surgery and artificial disc replacement. In addition to his clinical work, Dr. Bae has spent a great deal of time researching stem cell repair for degenerative disc disease and the use of growth factors to treat spinal cord injuries.
